Lower cholesterol level on admission predicts poor outcome after prolonged cardiac arrest

Area of Science:

• Cardiology
• Neurology
• Critical Care Medicine

Background:

• Higher cholesterol is a known risk factor for coronary artery disease and sudden cardiac death (SCD).
• Previous studies have shown paradoxical worse outcomes in SCD patients with lower cholesterol levels, necessitating further clarification of cholesterol's prognostic role.

Purpose of the Study:

• To investigate the association between on-admission cholesterol levels and neurological outcomes in patients with refractory cardiac arrest.
• To determine if total, HDL, and non-HDL cholesterol levels predict neurological recovery after cardiac arrest.

Main Methods:

• Secondary analysis of the randomized Prague OHCA trial, including 123 patients with refractory cardiac arrest.
• Assessment of total, HDL, and non-HDL cholesterol levels on admission.
• Evaluation of neurological outcome using the Cerebral Performance Category (CPC) scale within 180 days.
• Comparison of cholesterol levels between patients with good (CPC 1-2) and poor (CPC 3-5) neurological outcomes.

Main Results:

• Patients with better neurological outcomes (CPC 1-2) had significantly higher on-admission levels of total cholesterol, non-HDL cholesterol, and HDL cholesterol compared to those with poorer outcomes (CPC 3-5).
• Lower total and non-HDL cholesterol levels were consistent predictors of poor neurological outcomes across all treatment groups (extracorporeal cardiopulmonary resuscitation and standard approach).
• Chronic statin use did not significantly influence the neurological outcome.

Conclusions:

• On-admission lower total and non-HDL cholesterol levels are associated with worse neurological outcomes in patients with refractory cardiac arrest.
• Cholesterol levels may serve as a prognostic marker for neurological recovery following cardiac arrest, irrespective of treatment modality.